• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer

Crypto Reporter

Online magazine about cryptocurrencies, NFTs, DeFi, GameFi and other blockchain technologies

Visit Consensus in Hong Kong | February 1-3, 2027
Visit Consensus in Miami | May 4-6, 2027
Use promo code CRYPTOREPORTER15 for a 15% discount on tickets
  • News
    • News Feed
    • Crypto news in brief
    • Stats & trends
  • Press Releases
  • Events
    • Upcoming Events
      • CryptoCon, Sydney (November 28–29, 2026)
      • iCrypto Awards: People’s Choice, Dubai (December, 2026)
      • Digital Asset Forum, London (February 1-2, 2027)
      • Consensus, Hong Kong (February 1-3, 2027)
      • Digital Assets Week, Dubai (February 4, 2027)
      • Digital Assets Week, Hong Kong (March 3, 2027)
      • 6th FinTech Week & Expo, Paris (May 4-5, 2027)
      • Consensus, Miami (May 4-6, 2027)
    • Past Events

PR: Shivom partners with Lifebit to power AI analysis of DNA data for clinical trials

December 13, 2018 By Crypto Reporter PR

Shivom, the blockchain genomics platform that is powering personalized healthcare, has partnered with Lifebit, the AI-powered DNA-analysis firm, to give users unprecedented reporting capabilities for DNA data analysis.

The partnership will mean that immediate Genome Wide Association Study (GWAS) analysis is possible, with no specialist knowledge or in-house data scientist required. It also means that users can access a library of pipelines (ready built softwares that are used for analysis) and an AI-powered toolkit for analysing the data in a way that is far more scalable than other solutions.

Another aspect that makes the Shivom platform superior to other genomics platforms is that it will give pharmaceutical organisations and life science users the ability to access real-time analysis whenever they need it with no waiting time, no application process for accessing the data and deadlines or cut off dates that restrict their access.

“Through this partnership with Lifebit, we are providing enterprise users with the tools they need to find the right patients for their clinical trials more easily and more accurately than is possible through other solutions. Not only that, it brings AI into GWAS analysis in a way that hasn’t been seen before,” said Dr Axel Schumacher, Co-Founder and Chief Scientific of Shivom.

The use of genomics platforms to improve rare disease treatment has increased in recent months, with 23andMe partnering with GlaxoSmithKline to develop drugs for Parkinson’s. However, the Shivom Lifebit partnership demonstrates a major leap forward in this area because it adds AI and Machine Learning capabilities to the identification of potential patients.

To do this, users will be able to access a library of pipelines within the Shivom platform. These include preset Shivom pipelines, those created through open source software and any that an enterprise chooses to develop using Github and DOCKER services.

“Our partnership with Shivom will allow us to combine unique datasets with a level of analysis automation and insight generation that has never been seen before on a genomics platform,” said Dr. Maria Chatzou, co-founder and CEO of Lifebit. “In this way, scientists and doctors will be able to get all the benefits of this rich database without the need to rely on a data scientist for help. On the other hand, still ensuring that the individuals that have provided data to Shivom are given a level of security and control only a state-of-art blockchain technology can offer.”

The partnership with Lifebit comes with the Shivom platform having already been released in alpha. The full launch of the platform is expected in Q1 2019.

About Shivom
Shivom is powering the next era of genomics through blockchain technology – protecting identity, personalizing healthcare and transforming lives. For the first time ever, a precision medicine ecosystem will offer an open web-marketplace for other providers to add not only genomics information, but also analytics and associated apps and services to drive personalized medicine. Shivom intends to extend its services to form a global network of associated laboratories and research centres, as well as genetic counsellors and other relevant services.
For further information, please visit: https://shivom.io/

About Lifebit
Lifebit is building a cloud-based cognitive system that can reason about DNA data like humans do. This offers researchers/R&D professionals, and their corresponding organisations (ie. pharmas), a highly scalable, modular and reproducible system that automates the analysis processes, learns from the data and provides actionable insights.
For further information, please visit: https://lifebit.ai

Filed Under: Press Releases

Primary Sidebar

Press Releases

Sumsub Identity Fraud Report: U.S. Has World’s Largest Fraud Network Detected as AI Agents Open New Gaps

November 18, 2026

Sentora and Fireblocks Dynamic partner to simplify yield access for crypto and fintech businesses

November 18, 2026

SWFI to Host G20 Digital Asset Round Table at G20 Investment Week in Miami on the Sidelines of the G20 Leaders’ Summit

November 18, 2026

How to Earn Solana as a Beginner: Copy Trading and Meme Coins on Banana Gun

November 17, 2026

GlobalStake Partners with Ledger Enterprise to Offer Native ETH Staking to Institutions

November 17, 2026

iCrypto Awards

Digital Asset Forum, London (February 1-2, 2027)

Consensus, Hong Kong (February 1-3, 2027)

6th Fintech Week & Expo, Paris (May 4-5, 2027)

Consensus, Miami (May 4-6, 2027)

Footer

Crypto Reporter is an online magazine about cryptocurrencies, NFTs, DeFi, GameFi and other blockchain technologies
About us
Contact us
Submit press-release

Search

2017-2026 Crypto Reporter